Cris Calsada | Chief Financial Officer |
Jay Hagan | President and Chief Executive Officer |
Denis Drygin | Chief Scientific Officer |
Brian Cheng | Cantor Fitzgerald |
Yi Chen | H.C. Wainwright |
Good afternoon, ladies and gentlemen and welcome to the Regulus Therapeutics Inc. Quarter 3 2021 Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded. I’d now like to turn the conference over to your host, Ms. Cris Calsada, Chief Financial Officer.